U-500 regular pork insulin offers some patients with insulin resistance improvement in metabolic regulation. This case report describes a 59-year-old diabetic woman with severe insulin resistance due to obesity. Discussion focuses on the types of insulin resistance, appropriate treatment, and benefits from U-500 insulin therapy.
Get full access to this article
View all access options for this article.
References
1.
Davidson MBInsulin therapy. In: Davidson MB, ed. Diabetes mellitus: diagnosis and treatment. New York: John Wiley & Sons, 1986:125-69.
2.
Marble A.Insulin in the treatment of diabetes. In: Marble A, Krale LP, Bradley RF, Christlieb AR, Soeldner JS, eds. Joslin's diabetes mellitus. 12th ed. Philadelphia: Lea & Febiger, 1985:397-405.
Kahn CRInsulin allergy and insulin resistance In: Kreiger DT, Bardin CW, eds. Current therapy in endocrinology and metabolism. St. Louis: CV Mosby, 1985:281-83.
6.
Flier JS, Kahn CR, Roth J.Receptors, antireceptors, antibodies and mechanisms of insulin resistance . N Engl J Med1979;300:413-19.
7.
Kahn CRRole of insulin receptors in insulin-resistant states. Metabolism1980;29:455-66.
8.
Kolterman OG, Insel J., Saekow M., Olefsky JMMechanisms of insulin resistance in human obesity. J Clin Invest1980;65:1272-84.
9.
Roth J., Muggeo M.Insulin receptors and hyperglycemia. In: Rifkin H, Raskin P, eds. Diabetes mellitus. Vol V. Bowie, Maryland: Robert J. Brady Company, 1981:63-77.
10.
Sotsky M., Shamoon H.Human insulin: a second revolution?Clin Diabetes1986;4:25.
11.
Schemthaner G. , Borkenstein M., Fink M., Mayr W., Menzel J., Schober E.Immunogenecity of human insulin (Novo) or pork monocomponent insulin in HLA-DR-typed insulin-dependent diabetic individuals. Diabetes Care1983;6:43-48.
12.
Baumann G., Drobny ECEnhanced efficacy of U-500 insulin in the treatment of insulin resistance caused by target tissue insensitivity. Am J Med1984;76:529-32.
13.
Nathan DM, Axelrod L., Flier JS, Carr DBU-500 insulin in the treatment of antibody-mediated insulin resistance. Ann Intern Med1981;94:653-56.
14.
Kolterman OG , Olefsky JMThe impact of sulfonylurea treatment upon the mechanisms responsible for the insulin resistance in type II diabetes . Diabetes Care1984;7:81-88.
15.
Baker DE, Campbell RKThe second generation sulfonylureas: glipizide and glyburide. Diabetes Educ1985;11:29-36.
